Safety, pharmacokinetics, and pharmacodynamic properties of oral DEBIO1143 (AT-406) in patients with advanced cancer: results of a first-in-man study.

Hurwitz, Herbert I; Smith, David C; Pitot, Henry C; Brill, Jeffrey M; Chugh, Rashmi; Rouits, Elisabeth; Rubin, Joseph; Strickler, John; Vuagniaux, Gregoire; Sorensen, J Mel; Zanna, Claudio

Hurwitz, Herbert I; Smith, David C; Pitot, Henry C; Brill, Jeffrey M; Chugh, Rashmi; Rouits, Elisabeth; Rubin, Joseph; Strickler, John; Vuagniaux, Gregoire; Sorensen, J Mel; Zanna, Claudio.

Affiliation

Hurwitz HI; Department of Medicine, Duke University School of Medicine, DUMC 3052, Durham, NC, 27710, USA, herbert.hurwitz@duke.edu.

Cancer Chemother Pharmacol ; 75(4): 851-9, 2015 Apr.

Article in En | MEDLINE | ID: mdl-25716544

Subject(s)

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Azocines / Benzhydryl Compounds / Neoplasms / Antineoplastic Agents Type of study: Clinical_trials / Etiology_studies Limits: Female / Humans / Male Language: En Journal: Cancer Chemother Pharmacol Year: 2015 Document type: Article Country of publication: Alemania

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google